how are glp 1 drugs administered GLP-1s: What They and They Work glp-1_analogs [TUSOM | Pharmwiki]

Sympathetic nervous system and inflammation: a conceptual view

The effect of prepregnancy body mass index on the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis

These data indicate that the actions of d-allulose to suppress food intake via GLP-1R signaling are preserved in multiple preclinical models of diabetes and obesity

For instance, in October 2024, a retrospective cohort study indicated that women with type 2 diabetes who used GLP-1 receptor agonists had a lower risk of developing new-onset uterine fibroids compared to those taking other antidiabetic drugs

Lund A, Knop FK, Vilsbll T: Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities

As per FMI, the market's valuation is increasingly uncoupled from diabetes prevalence alone, driven by regulatory endorsement of weight management indications and cardiovascular risk reduction claims that expand the addressable patient population by an order of magnitude [1]